Monochinkve

Monochinquer Description of the drug Monochinquer: Combined antianginal drug. Provides the release of isosorbide-5-mononitrate (the active substance of the drug) into the systemic circulation after 4-6 hours; does not change the oxygen content, but improves blood supply to the myocardium in comatose, shock conditions. In addition, it alleviates the condition of elderly patients with reduced left ventricular function. Treatment begins with 2 tablets. 3 times/day. The dose is adjusted depending on the severity of the symptoms of the disease. Maintenance treatment: 1 tablet. 2-3 times/day - maximum daily dose - 6 tablets (80 mg). Monochinkivi is a selective venous vasodilating drug whose active ingredient is isosorbide-5-nitrate. Nitrates, according to modern concepts, increase both general and perfusion oxygen supply to the myocardium. The main mechanism of action of the drug is to lengthen the time of diastolic filling of the ventricles of the heart with blood. The effect occurs 5-15 minutes after ingestion and continues until the active substance is removed from the body. The drug activates the absorption and use of oxygen by the myocardium in patients suffering from cardiac